09Oct
Caremark Round II: Beware Red Flags in Drug Development
On October 1, 2019, the Delaware Court of Chancery applied the Delaware Supreme Court’s recent decision on Caremark board oversight claims in the context of operating in a highly regulated industry to allow derivative claims to proceed against the...
By:
Goodwin
Related
The New York State Department of Health (DOH) recently issued a Request for Offers (RFO) from eligib...
Read More >
Effective December 31, 2019, Pennsylvania amended section 6344(m) of the Child Protective Services L...
Read More >
The oil price plunge starting on March 6 seems like a sucker-punch to the oil and gas industry after...
Read More >
The Southern District of New York declared that plaintiff Monjasa A/S was not bound by an arbitratio...
Read More >
The Ministry of Justice and Law issued Resolution No. 806 of June 4, 2020, implementing important ch...
Read More >
On May 1, Mexico adopted sweeping changes to its labor laws, ushering in a new era of labor relation...
Read More >